Nomen | RU, (LVIII) DCCCXLI |
Cas numerum | 154992-24-2 |
MOLECULA | C17h18f3n3o3 |
Pondus | 369,34 |
Einecs numerum | 1592732-453-0 |
PRAETERITUS | 493.6 ± 55.0 ° (Praedicta) |
Densitas | 1.39 |
Repono condicionem | Signatum in sicco, copia in freezer, sub -20 ° C |
Forma | Pulverem |
Colo | Alba |
Stipare | PE lapides sacculi + Aluminium |
Ru58841; 4- (4,4-Dimethyl, 2,5-dioxo-3- (IV-hydroxybutyl) I-imidazolidinyl) -2- (trifloromethyl) Benzo Nitrile; 4 [3 (IV-hydroxybutyl) -4,4-Dimethyl, 2,5-dioxo-I-imidazolidinyl] -2- (trifluoromethyl) Benz Onitrile; 4 [3 (-IV-hydroxybutyl) -4,4-Dimethyl, 2,5-dioxoimidazolidin-I-yl] -2- (trifluoromethyl) Ben Zonitriile; Ru-58841E: Candyli (ad) SpeedgainPharma (DOT) com; CS-DCXXXVII; Ru588841; Ru58841; Ru58841; RU, (LVIII) DCCCXLI
Descriptio
RU (LVIII) DCCCXLI (PSK MMMDCCCXLI,) est Androgen receptor Ancharonist quod promovet capillus regrowth.Ru58841 est investigational medicamento creavit pro curatio contra Ancythenic Alopecia, etiam notum ut masculum exemplar calvitium (MPD).
Ut a topicus anti-androgen, principium agendi non est idem quod de finasteride. Directe agit in 5α reductase, inhibits conversionem testosterone in DHT et reduces contentus DHT in corpore. Ru58841 cuneos contactus inter dihydrotestosterone et capillos folliculus receptatores, non directe reducere DHT contentus, sed reduces binding of DHT et capillos folliculus receptores.
4 [3 (IV-hydroxybutyl) -4,4-Dimethyl, 2,5-dioxo-I-imidazolidinyl] -2- (trifluoromethyl) Benzonitres potest esse ut medicina eget synthesim intermedia.Si 4 [3 (IV-hydroxybutyl) -4,4-Dimethyl, 2,5-dioxo-I-imidazolidinyl] -2- (trifluoromethyl) benzonitrile est attrahitur, movere a aerem aere;In casu cutis contactu, removere contaminari indumentis intus stupam cutis penitus saponem et aquam et quaerite medical operam si molesta occurs;
Parte effectus
Ru58841 applicatur ad cutem, absorbuit a comas folliculis et in speculatice, potest intrare sanguinem et afficit aliis partibus corporis. Sed non systemica parte effectus sunt in studiis ex topici application in simiarum. Autem, quidam qui conatus Ru58841 clamore sunt periti aliqua possibile latus effectus ex usura RU, inter cutis irritatio, minuatur libido, erectile distemperantia, nausea, rubrum oculos, vertigine et capitis.